Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
A clinical trial is a research study designed to evaluate a medical intervention's safety, efficacy, and/or effectiveness, such as a new drug, therapy, medical device, or treatment procedure. These trials are conducted with human participants, often patients, to assess the potential benefits and risks of the intervention.
Clinical trials are typically conducted in multiple phases: Phase I, Phase II, Phase III, and Phase IV.
Clinical trials follow strict protocols and are conducted under the supervision of trained medical professionals and researchers. Participants in clinical trials are required to provide informed consent after receiving detailed information about the study's objectives, procedures, potential risks, and benefits.
These trials are the first step in testing a new intervention in humans. They primarily focus on assessing the intervention's safety and dosage levels.
Length of Study: Several months
Approximately 70% of drugs move to the next phase.
Phase two tests the treatment on a larger group of patients to evaluate safety, dosage, and efficacy.
Length of Study: Several months to 2 years
Approximately 33% of drugs move to the next phase.
Phase III trials confirm treatment effectiveness, compare with standard treatments, and evaluate safety and side effects among a larger patient population.
Length of Study: 1 to 4 years
Approximately 25-30% of drugs move to the next phase
Phase IV trials are conducted after regulatory approval to monitor the intervention's long-term safety and effectiveness in real-world settings, identifying rare or long-term side effects.
Clinical trials allow people from different backgrounds and with various health conditions to participate in medical research. Anyone can participate, regardless of age, health, ethnicity, or social background. There's usually no need for insurance, proof of legal status, or citizenship. These trials may involve healthy volunteers or individuals with specific illnesses or medical conditions.
Clinical trials offer advanced investigational therapies that can help those who have exhausted standard treatments or seek alternatives.
Participating in clinical trials advances medical science, improves patient care, and helps develop new treatments for diseases while enhancing existing therapies.
Clinical trial participants receive ongoing monitoring and medical attention from experienced professionals to detect and treat health issues early, promoting well-being.
Clinical trial participation may lead to improved health outcomes, including better symptom management, disease control, or remission due to investigational treatments.
Clinical trial participants may receive compensation for their time, travel expenses, and other costs.
Clinical trials offer a chance for empowerment and emotional support by connecting individuals facing similar health challenges.
Clinical trials benefit public health by developing safe and effective treatments.
Patient consent is fundamental in clinical research. At MQRA, we prioritize the highest ethical standards and informed consent in our trials. Our team ensures a transparent consent process, providing clear information to participants. We adhere to guidelines and ethical principles to safeguard participants and build trust through communication and support. Our goal is to advance medical science with integrity and compassion.
We prioritize the privacy of participant information in our clinical trial operations at MQRA. We comply with HIPAA regulations and maintain strict confidentiality standards by implementing robust policies, procedures, and technologies. Our measures include access controls, encryption protocols, regular audits, and ongoing staff training. By doing so, we uphold participant trust, preserve research integrity, and prioritize data privacy.
2908 West Waters Avenue, Suite 101A Tampa, Florida 33614
Open today | 09:00 am – 05:00 pm |
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.